Bristol-Myers Squibb Co BMY:NYSE

Last Price$64.53Cboe Real-Time Last Sale as of 11:56AM ET 1/18/22
Cboe Real-Time Quotes
Realtime quote and/or trade prices are not sourced from all markets
Today's Change-0.40(0.62%)
Bid (Size)$64.51 (400)
Ask (Size)$64.53 (200)
Day Low / High$63.82 - 64.98
Volume3.9 M
 

View Pharmaceuticals: Major IndustryPeer Comparison as of 01/18/2022

 

Bristol-Myers Squibb Co ( NYSE )

Price: $64.53
Change: -0.40 (0.62%)
Volume: 3.9 M
11:56AM ET 1/18/2022
 
 

Merck & Co Inc ( NYSE )

Price: $81.84
Change: +0.46 (0.57%)
Volume: 4.9 M
11:56AM ET 1/18/2022
 
 

Eli Lilly and Co ( NYSE )

Price: $245.99
Change: +1.87 (0.77%)
Volume: 881.3 K
11:56AM ET 1/18/2022
 
 

Abbvie Inc ( NYSE )

Price: $137.01
Change: +1.14 (0.84%)
Volume: 3.3 M
11:56AM ET 1/18/2022
 
 

Biohaven Pharmaceutical Holding Company Ltd ( NYSE )

Price: $119.02
Change: -3.15 (2.58%)
Volume: 254.3 K
11:56AM ET 1/18/2022
 

Read more news Recent News

Evotec, Bristol Myers Expand Neurogenerative Partnership to Include New Targeted Protein Degradation Approach
2:18PM ET 1/11/2022 MT Newswires

Evotec (EVO) said Tuesday that it expanded its partnership with Bristol Myers Squibb (BMY) to include a new approach toward targeted protein degradation to...

Evogene's Biomica Gets Israeli Nod To Move Ahead With Cancer Trial
7:24AM ET 1/11/2022 MT Newswires

Evogene's (EVGN) Biomica unit said Tuesday it has received Israeli approval to carry out a Phase 1 trial of BMC-128 in combination with Bristol Myers...

BioAlta, Bristol Myers Squibb Partnering on Potential Cancer Treatments
4:27PM ET 1/10/2022 MT Newswires

BioAtla (BCAB) late Monday said it has began a clinical collaboration with Bristol Myers Squibb (BMY) to investigate potential combinations of BioAtla's...

Century Therapeutics, Bristol Myers Squibb Sign Cancer Research Collaboration Agreement
8:23AM ET 1/10/2022 MT Newswires

Century Therapeutics (IPSC) said Monday it has entered into a research collaboration and license agreement with Bristol Myers Squibb (BMY) to develop...

Company Profile

Business DescriptionBristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers chemically-synthesized drugs or small molecules and products produced from biological processes called biologics. The company was founded in August 1933 and is headquartered in New York, NY. View company web site for more details
Address430 East 29th Street
New York, New York 10016
Phone+1.212.546.4000
Number of Employees23,300
Recent SEC Filing01/10/20228-K
Chairman & Chief Executive OfficerGiovanni Caforio
Chief Financial Officer & Executive Vice PresidentDavid V. Elkins
Chief Information Officer & Executive VPPaul von Autenried
Executive VP-Research & Early DevelopmentRupert J. Vessey

Company Highlights

Price Open$64.68
Previous Close$64.93
52 Week Range$53.22 - 69.75
Market Capitalization$143.2 B
Shares Outstanding2.2 B
SectorHealth Technology
IndustryPharmaceuticals: Major
Current Dividend / Yield$0.54 / 3.33%
Dividend Ex-Date01/06/2022
Dividend Pay-Date02/01/2022
Dividend Yield 5 Year Average2.81%
Next Earnings Announcement02/04/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share$1.74
Beta vs. S&P 500N/A
Revenue$22.6 B
Net Profit Margin-11.89%
Return on Equity-14.47%

Analyst Ratings as of 01/17/2022

Buy
11
Overweight
2
Hold
11
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset